Dr. Rajesh Ponugupati. “EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL”. Journal of Population Therapeutics and Clinical Pharmacology 23, no. 2 (May 25, 2016): 237–246. Accessed September 17, 2026. http://www.jptcp.com/index.php/jptcp/article/view/13050.